Health Care/Hospital
Genscript Biotech Reports 2022 Annual Results*
Non-Cell Therapy Achieved 31.4% Adjusted Net Profit Growth Cell Therapy Business Revenue Surged By 70% * Revenue of the Group for the year ended December 31, 2022 was approximately US$625.7 million, representing an increase of 27.7% as compared with approximatelyUS$490.1 million for the year e...
2023-03-31 08:40
2681
We are Literally Sleeping on a Petri Dish
Mattress Testing by 10:PM Reveals Ultra Ick Findings SYDNEY, March 30, 2023 /PRNewswire/ -- 30% of the weight of a mattress is made of dried epidermis particles, from your skin and that of anyone else who has ever been on your bed. This is just one finding from new eco Aussie mattress brand, 10:...
2023-03-31 07:31
2067
Everest Medicines Announces Financial Results for Full Year Ended December 31, 2022
SHANGHAI, March 31, 2023 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on developing, manufacturing and commercializing transformative pharmaceutical products and vaccines, today announced its financial results for the full year...
2023-03-31 07:30
3558
NADclinic Group, BioStarks and Do Not Age Announce Exclusive Partnership to Revolutionise Personalised Longevity
LONDON, March 31, 2023 /PRNewswire/ -- NADclinic Group, BioStarks and Do Not Age have joined forces in an exclusive partnership to provide their audience with innovative solutions, combining cutting edge diagnostics, therapeutics and best in class longevity focused supplements and nutraceuticals....
2023-03-31 03:03
2346
Oncoclínicas Group ends 2022 with record net revenue of BRL 4.1 billion
* Revenue grew 51.3%, of which 29.5% were organic, driven by larger volume of treatments; * The company's net profit in 2022 was BRL 114 million; * EBITDA reached BRL 673 million, 80% higher than in 2021. SÃO PAULO, March 31, 2023 /PRNewswire/ -- Oncoclínicas Group (ONCO3) – the largest grou...
2023-03-31 00:43
2161
Croma-Pharma: Further strengthening its portfolio with PhilArt biostimulators
VIENNA, March 31, 2023 /PRNewswire/ -- Croma (Croma-Pharma® GmbH) is a global player and challenger in the dynamically growing, minimally invasive aesthetics market and a leading manufacturer of premium quality hyaluronic acid (HA) syringes. With the launch of PhilArt, a complete series of inject...
2023-03-31 00:33
1869
Kintor Pharma Announces 2022 Annual Results and Recent Business Progress
SUZHOU, China, March 30, 2023 /PRNewswire/ -- Kintor Pharmaceutical Limited (Kintor Pharma, HKEX: 9939), a clinical-stage biotechnology company developing innovative small molecules and biological therapeutics, today announced business highlights and financial results for the year ended31 Decembe...
2023-03-31 00:33
2908
Viva Biotech Announced 2022 Annual Results:
Revenue and Gross Profit with Steady Growth Competitive Advantages of One-stop Platform Continuously Demonstrating Financial highlights of the year ended December 31, 2022: * Revenue amounted to RMB2,379.6 million, representing a year-on-year (YoY) increase of 13.1% * Gross profit amounted to...
2023-03-31 00:25
3420
Sisram Medical Expands Footprint in Mainland China, Acquires Giant Medical Aesthetic Distributor - PhotonMed
HONG KONG, March 30, 2023 /PRNewswire/ -- Sisram Medical Ltd (the "Company" or " Sisram",: 1696.HK; together with its subsidiaries collectively referred to as the "Group"), a global leading innovator and provider of medical aesthetic devices, has announced that Alma Lasers ("Alma"), a wholly-owned...
2023-03-30 23:57
3392
7 Out Of 10 Gen Z Will Keep Being Vegan In The Next 5 Years - Gen Z Is Leading The Veganism Trend, Data Says
INDIANAPOLIS, March 30, 2023 /PRNewswire/ -- The plant-based food market is
expected to continue to boom in the near future with Generation Z being the
main driving force. But what does the future look like? According to a recent
survey conducted byMIDDS
2023-03-30 23:48
2109
Croma-Pharma: Further strengthening its portfolio with PhilArt biostimulators
VIENNA, March 30, 2023 /PRNewswire/ -- Croma (Croma-Pharma® GmbH) is a global player and challenger in the dynamically growing, minimally invasive aesthetics market and a leading manufacturer of premium quality hyaluronic acid (HA) syringes. With the launch of PhilArt, a complete series of inject...
2023-03-30 22:52
1822
HistoSonics Announces First Ever Kidney Tumor Treatment Using Histotripsy
Leeds Teaching Hospitals NHS Trust, (UK) Performs Non-Invasive Histotripsy in
Patient with Primary Solid Renal Tumor
MINNEAPOLIS, March 30, 2023 /PRNewswire/ -- HistoSonics, (www.histosonics.com
2023-03-30 22:12
1675
DISCOVERY LIFE SCIENCES INSTALLS WORLD'S LARGEST COMMERCIAL FLEET OF NOVASEQ X PLUS SYSTEMS TO ACCELERATE GENOMIC RESEARCH WITH UNPRECEDENTED SPEED AND COST EFFICIENCY
HUNTSVILLE, Ala., March 30, 2023 /PRNewswire/ -- Discovery Life Sciences™ (Discovery), the Biospecimen and Biomarker Specialists™, has announced that Discovery Genomics is the first commercial service laboratory in the world to receive two of the new NovaSeq™ X Plus Sequencing Systems from Illumi...
2023-03-30 21:05
1950
IMG Travel Outlook Survey Predicts Continued Surge of International Travel in 2023
* Survey results reveal travel trends for 2023 including frequency of travel, timing of travel, and anticipated spending habits of travelers INDIANAPOLIS, March 30, 2023 /PRNewswire/ -- International Medical Group® (IMG®), an award-winning global insurance benefits and assistance services compa...
2023-03-30 21:00
1532
Actinogen presents positive Phase 2a Xanamem data in at ADPD™ Alzheimer's and Parkinson's diseases conference
A longitudinal dataset indicating the utility of plasma pTau for patient selection in clinical trials of patients with mild Alzheimer's Disease (AD) and the likely therapeutic benefit of oral Xanamem in this population SYDNEY, March 30, 2023 /PRNewswire/ -- Actinogen Medical ASX: ACW ("ACW" or "...
2023-03-30 21:00
1555
ACROBiosystems' new strategic focus - streamlining the transition from preclinical development to commercialization
BASEL, Switzerland, March 30, 2023 /PRNewswire/ -- ACROBiosystems has begun to narrow its focus into helping accelerate the process between preclinical, clinical and commercialization. With over 10 years development, ACROBiosystems continues to surprise and bring new solutions to the pharmaceutic...
2023-03-30 20:51
1747
Zhongchao Inc. Announces Launch of Health Education Intelligent Content Production Platform
SHANGHAI, March 30, 2023 /PRNewswire/ -- Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), a platform-based internet technology company offering services to patients with cancer and other major diseases, today announced the launch of "E-Class," medical education intelligent content p...
2023-03-30 20:00
1494
Turn Biotechnologies Introduces its Dermatology Platform to the European Aesthetic Community at AMWC
MOUNTAIN VIEW, Calif., March 30, 2023 /PRNewswire/ -- Turn Biotechnologies, a cell rejuvenation company developing novel mRNA medicines to cure untreatable, age-related conditions, announced that it will for the first time share new data for its revolutionary dermatology platform with the interna...
2023-03-30 20:00
2891
ACROBiosystems' new strategic focus - streamlining the transition from preclinical development to commercialization
NEWARK, Del., March 30, 2023 /PRNewswire/ -- With more than 10 years of experience in protein development, ACROBiosystems has continuously demonstrated its strength in developing products and services throughout the entire drug development process. As such, ACROBiosystems has begun to narrow its ...
2023-03-30 18:54
1726
DxVx Co., Ltd.'s affiliated company, Oxford Vacmedix (OVM) successfully completed Phase 1a in clinical trial of novel cancer vaccine OVM-200
SEOUL, South Korea, March 30, 2023 /PRNewswire/ -- DXVX announces that its affiliated company Oxford Vacmedix (OVM) has completed Phase 1a trial of cancer vaccine and plans to proceed Phase1b trial of OVM-200. DxVx Co., Ltd. is the Korean Stock market (KOSDAQ) listed company and is the largest s...
2023-03-30 17:39
1648
Week's Top Stories
Most Reposted
LINKDOOD Breaks Language Barriers, Ushering a New Era for Cross-Border Romance
[Picked up by 326 media titles]
2024-04-29 06:00
Dow showcases circular and innovative materials science solutions and industry collaborations at Chinaplas 2024
[Picked up by 293 media titles]
2024-04-30 10:11
Puyuan Fashion Resort 2024: A Grand Unveiling of Global Trends and Local Heritage
[Picked up by 269 media titles]
2024-04-28 09:39
TAILG Makes Grand Appearance at 2024 Asiabike Jakarta, Aiming to Set the Benchmark in Indonesia
[Picked up by 257 media titles]
2024-05-02 01:21
Chinese new energy industry contributes to global green, low-carbon transition
[Picked up by 251 media titles]
2024-04-30 15:13Most Read
Scienjoy Holding Corporation Reports Fiscal Year 2023 Financial Results
2024-04-27 04:30
2941
